Control of vampire bats is accomplished by capture of individual bats, application of a slow-acting toxicant to the bodies of the individuals, and subsequent release of the treated bats. After release, the bats return to their roosting sites where the toxicant is spread to other vampires, resulting in death of a large percentage of the bats.

A method of treating Theileriosis in cattle and sheep both therapeutically and prophylactically, comprising the administration of an effective amount of a compound which is a 2-hydroxy-1,4-naphthoquinone derivative of formula (I) or a pharmaceutically acceptable salt thereof, ##STR1## WHEREIN N IS ZERO OR 1 TO 12, AS ACTIVE INGREDIENT, TO AN ANIMAL WHICH IS SUSCEPTIBLE AND INFECTED WITH OR POTENTIALLY EXPOSED TO AN INFECTION WITH Theileria species.

Naphthoquinone ethers are useful as miticides having improved knockdown characteristics.

A vitamin K mixture is used in a topical application for the treatment of blood vessel disorders of the skin which include, but are not limited to, actinic and iatrogenic purpura, lentigines and other vascular problems of the skin and subcutaneous tissue. The formulation of the mixture includes a number of the following substances: vitamin K, 95% ethyl alcohol SD40, isopropyl alcohol 99%, benzyl alcohol, lecithin granules, isopropyl palmitate NF, propyl paraben, methyl paraben, Pluronic F-127 NF...

With an object of providing an agent for treating hepatic disease by inhibiting occurrence of hepatic disease, in particular portal venous invasion, there is disclosed an agent for treating or preventing hepatic disease containing menatetrenone as an active ingredient thereof. This agent for treating or preventing hepatic disease is effective against hepatic cancer, in particular DCP (des-.gamma.-carboxy prothrombin) positive hepatic cancer. Moreover, the agent for treating or preventing hepatic...

The invention relates to a new use of menaquinone, and more particularly, to a method of medical treatment of asthma by administering menaquinone.

Allergic conditions such as asthma, hay fever and rhinitis are treated with daily doses of 2-nitroindan-1,3-dione or the equivalent amount of a pharmaceutically acceptable salt orally, parenterally or by insufflation. The salt is an alkali metal salt or a salt with an organic base such as an amine or amino compound. The average daily dose is 400-700 mg.

Compositions having rodenticidal activity are disclosed which are constituted by a solution of a compound having anti-coagulant activity and which is an indane dione or a 4-hydroxycoumarin, preferably chlorophacinone, diphacinone, bromadiolone or coumachlor, in a glycol in admixture with a volatile co-solvent, preferably acetone or dichloromethane, which increases the solvent activity of the glycol for the anti-coagulant compound. The composition is stable and may be applied to solid or liquid b...

A mammal suffering from allergic disease due to SRS-A, such as skin symptoms, asthma, rhinitis, etc. is treated by administering to said mammal an effective amount of a compound of the formula: ##STR1## wherein R is methoxy or methyl, or two R's taken together represent --CH.dbd.CH--CH.dbd.CH--; and n is an integer of 4 to 22.

Malignant melanoma cells spontaneously generate reactive oxygen species (ROS) that promote constitutive activation of the transcription factor nuclear factor-kB (NF-kB). Although antioxidants and inhibitors of NAD(P)H oxidases significantly reduce constitutive NF-kB activation and suppress cell proliferation, the nature of the enzyme responsible for ROS production in melanoma cells has not been determined. To address this issue, we now have characterized the source of ROS production in melanoma ...